• 

  July 23, 2025

  TISSIUM’s COAPTIUM Connect ushers in photopolymer 3‑D printing for implantables

  R.D. Solorzano

• 

  July 16, 2025

  CollPlant Expands U.S. Footprint with Strategic Hire to Lead Commercial GrowthBusiness of Biofabrication

  R.D. Solorzano

• 

  July 10, 2025

  Tissue Regenix recent results and what to watch

  R.D. Solorzano

• 

  July 2, 2025

  Vertex’s Zimislecel Shows Early Promise for Insulin Independence

  R.D. Solorzano

• 

  June 26, 2025

  3DBioFibR Secures $3M to Scale High-Performance Biopolymer Fiber Manufacturing

  William Ernst

• 

  June 25, 2025

  Biofabricated Organ Support: miroliverELAP’s First Human Treatment for Acute Liver Failure

  R.D. Solorzano

• 

  June 4, 2025

  Vivodyne Raises $40M to Scale AI and Robotics-Driven Human Tissue Platform for Drug Discovery

  William Ernst

• 

  May 6, 2025

  VivoSim Labs Introduces NAMkind Platform for Human-Based Drug Testing Models

  R.D. Solorzano

• 

  April 27, 2025

  Organovo Rebrands as VivoSim Labs to Advance 3D Bioprinting Technology

  R.D. Solorzano

• 

  April 3, 2025

  Organovo Sells FXR Drug Program to Eli Lilly in Strategic Deal to Advance IBD Therapies

  R.D. Solorzano